Opis działalności
BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world’s largest investors in this sector. BB Biotech is listed in Switzerland, Germany and Italy. Its investments are focused on listed companies that are developing and commercializing novel medical treatments and cures. BB Biotech’s investment selection process is guided by the fundamental research and analysis of physicians and molecular biologists. Its Board of Directors has many years of experience in industry and science.
Zarząd & Rada nadzorcza
| CEO |
| - |
| Zarząd |
| - |
| Rada nadzorcza |
| Dr. Thomas von Planta, Dr. Clive Meanwell, Laura Hamill, Dr. Pearl Huang, Camilla Soenderby, Prof. Dr. Mads Krogsgaard Thomsen |
Dane firmy
| Nazwa: |
BB Biotech AG |
| Adres: |
Schwertstraße 6,CH-8200 Schaffhausen/Schweiz |
| Telefon: |
+41-52-624-0845 |
| Fax: |
- |
| E-mail: |
info@bbbiotech.com
|
| Internet: |
www.bbbiotech.com |
| Przemysł: |
Dostawca usług finansowych |
| Sektor: |
Specjalne Usługi Finansowe |
| Podsektor: |
Różne Usługi Finansowe |
| Koniec roku finansowego: |
31.12 |
| Free float: |
100,00% |
| Data IPO: |
10.12.1997 |
Relacje inwestorskie
| Nazwa: |
Dr. Silvia Siegfried-Schanz |
| Telefon: |
+41-44-267-7266 |
| Fax: |
- |
| E-mail: |
ssc@bellevue.ch
|
